HDACs in skeletal muscle remodeling and neuromuscular disease

Handbook of Experimental Pharmacology

Volumn 206, Issue , 2011, Pages 79-101

  Simmons, Bryan J ^a   Cohen, Todd J ^a   Bedlack, Richard ^a   Yao, Tso Pang ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; HDAC; HDAC inhibitor; HDAC4; Muscle atrophy; Muscle remodeling

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CHOLINERGIC RECEPTOR; GLUCOSE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; SIRTUIN 1; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY MASS; CALCIUM SIGNALING; CARBOXY TERMINAL SEQUENCE; CUTANEOUS T CELL LYMPHOMA; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; EPILEPSY; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; MOOD DISORDER; MOTONEURON; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FIBRIL; MUSCLE INNERVATION; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE REGENERATION; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE SPECIFICITY; TISSUE STRUCTURE; TISSUE TYPES;

ACETYLATION; ANIMALS; CALCIUM SIGNALING; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; REGENERATION;

EID: 80054772221     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-21631-2_5     Document Type: Article

References (102)

1. Alderton JM, Steinhardt RA (2000) Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J Biol Chem 275(13):9452-9460 (Pubitemid 30185173)
2. Al-Khalili L et al (2005) Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. Diabetologia 48(6): 1173-1179 (Pubitemid 40909654)
3. Aronson D, Dufresne SD, Goodyear LJ (1997) Contractile activity stimulates the c-Jun NH2-terminal kinase pathway in rat skeletal muscle. J Biol Chem 272(41):25636-25640 (Pubitemid 27438878)
4. Backs J et al (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 116(7):1853-1864 (Pubitemid 44033310)
5. Bassel-Duby R, Olson EN (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75:19-37 (Pubitemid 44118024)
6. Black BL, Olson EN (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14:167-196 (Pubitemid 29001453)
7. Bodine SC et al (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294(5547):1704-1708 (Pubitemid 33104839)
8. Bolger TA et al (2007) The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J Biol Chem 282(40):29186-29192 (Pubitemid 350043333)
9. Bottomley MJ et al (2008) Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 283(39): 26694-26704
10. Bradner JE et al (2010) Chemical phylogenetics of histone deacetylases. Nat Chem Biol 6(3): 238-243
11. Buller AJ, Eccles JC, Eccles RM (1960) Interactions between motoneurones and muscles in respect of the characteristic speeds of their responses. J Physiol 150:417-439
12. Camargo FD et al (2003) Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 9(12):1520-1527 (Pubitemid 38004780)
13. Chang S et al (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24(19):8467-8476 (Pubitemid 39245069)
14. Chin ER, Allen DG (1996) The role of elevations in intracellular [Ca2+] in the development of low frequency fatigue in mouse single muscle fibres. J Physiol 491(Pt 3):813-824
15. Chin ER et al (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12(16):2499-2509 (Pubitemid 28406953)
16. Cohen TJ et al (2007) The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J Biol Chem 282(46):33752-33759 (Pubitemid 350159508)
17. Cohen TJ et al (2009) The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J 23(1):99-106
18. Colussi C et al (2008) HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA 105 (49):19183-19187
19. Cui SS et al (2003) Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res 975(1-2):229-236
20. Czubryt MP et al (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100(4):1711-1716 (Pubitemid 36254513)
21. De Koninck P, Schulman H (1998) Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 279(5348):227-230 (Pubitemid 28103880)
22. Deng X et al (2005) Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J Biol Chem 280(6):4894-4905 (Pubitemid 40288664)
23. Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47(6(suppl 4)): S233-S241 (Pubitemid 26422576)
24. Esser K et al (1999) The CACC box and myocyte enhancer factor-2 sites within the myosin light chain 2 slow promoter cooperate in regulating nerve-specific transcription in skeletal muscle. J Biol Chem 274(17):12095-12102
25. Finsterer J (2009) Bulbar and spinal muscular atrophy (Kennedy's disease): a review. Eur J Neurol 16(5):556-561
26. Fischle W et al (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9(1):45-57 (Pubitemid 34127770)
27. Gomes MD et al (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98(25):14440-14445 (Pubitemid 33121410)
28. Grefte S et al (2007) Skeletal muscle development and regeneration. Stem Cells Dev 16(5): 857-868 (Pubitemid 350125232)
29. Gregoire S, Yang XJ (2005) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol Cell Biol 25(6):2273-2287 (Pubitemid 40354624)
30. Gregoire S et al (2007) Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol 27(4):1280-1295 (Pubitemid 46239812)
31. Grimaldi PA (2003) Roles of PPARdelta in the control of muscle development and metabolism. Biochem Soc Trans 31(Pt 6):1130-1132 (Pubitemid 38030923)
32. Grozinger CM, Schreiber SL (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 97(14):7835-7840 (Pubitemid 30460734)
33. Grozinger CM, Hassig CA, Schreiber SL (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci USA 96(9):4868-4873 (Pubitemid 29214503)
34. Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21(18):6091-6101 (Pubitemid 34263509)
35. Gupta MP et al (2008) HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J Biol Chem 283(15):10135-10146
36. Haberland M, et al (2007) Regulation of HDAC9 gene expression by MEF2 establishes a negativefeedback loop in the transcriptional circuitry of muscle differentiation. Mol Cell Biol 27(2): 518-525 (Pubitemid 46080121)
37. Hawke TJ, Garry DJ (2001) Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91(2):534-551 (Pubitemid 32681081)
38. Hennig R, Lomo T (1985) Firing patterns of motor units in normal rats. Nature 314(6007):164-166 (Pubitemid 15137124)
39. Iezzi S et al (2004) Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 6(5):673-684 (Pubitemid 38579351)
40. Koh SD et al (1999) Novel regulation of the A-type K+ current in murine proximal colon by calcium-calmodulin-dependent protein kinase II. J Physiol 517(Pt 1):75-84 (Pubitemid 29243472)
41. Koves TR et al (2005) Peroxisome proliferator-activated receptor-gamma co-activator 1alphamediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 280(39):33588-33598 (Pubitemid 41397160)
42. Lahm A et al (2007) Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci USA 104(44):17335-17340 (Pubitemid 350219843)
43. Lange S et al (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308(5728):1599-1603 (Pubitemid 40807503)
44. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98(16):9306-9311 (Pubitemid 32743912)
45. Lemercier C et al (2000) mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem 275(20):15594-15599 (Pubitemid 30337295)
46. Lilly B et al (1995) Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267(5198):688-693
47. Lin J et al (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418(6899):797-801
48. Liu Y, Randall WR, Schneider MF (2005) Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. J Cell Biol 168(6):887-897 (Pubitemid 40397003)
49. Lu J et al (2000a) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6(2):233-244
50. Lu J et al (2000b) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA 97(8):4070-4075 (Pubitemid 30226088)
51. Marks PA (2007) Discovery and development of SAHA as an anticancer agent. Oncogene 26(9): 1351-1356 (Pubitemid 46328465)
52. Matthews SA et al (2006) Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol 26(4):1569-1577 (Pubitemid 43202580)
53. McCampbell A et al (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9(14):2197-2202
54. McGee SL et al (2009) Exercise-induced histone modifications in human skeletal muscle. J Physiol 587(Pt 24):5951-5958
55. McKinsey TA et al (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408(6808):106-111
56. McKinsey TA, Zhang CL, Olson EN (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27(1):40-47 (Pubitemid 34131624)
57. Mejat A et al (2005) Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nat Neurosci 8(3):313-321 (Pubitemid 40300188)
58. Minamiyama M et al (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 13(11):1183-1192 (Pubitemid 38787000)
59. Minetti GC et al (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12(10):1147-1150 (Pubitemid 44527349)
60. Miska EA et al (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18(18):5099-5107 (Pubitemid 29443811)
61. Molkentin JD et al (1995) Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83(7):1125-1136 (Pubitemid 26007804)
62. Moresi V et al (2010) Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases. Cell 143(1):35-45
63. Murgia M, et al (2000) Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat Cell Biol 2(3):142-147
64. Naya FJ et al (1999) Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development 126(10):2045-2052 (Pubitemid 29271690)
65. Nucifora FC Jr et al (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291(5512):2423-2428
66. Pallafacchina G et al (2002) A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99(14): 9213-9218 (Pubitemid 34764593)
67. Pandey UB et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447(7146):859-863 (Pubitemid 46920134)
68. Petri S et al (2006) Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 22(1):40-49
69. Potthoff MJ et al (2007a) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 117(9):2459-2467 (Pubitemid 47494347)
70. Potthoff MJ et al (2007b) Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol Cell Biol 27(23):8143-8151 (Pubitemid 350234229)
71. Rajan I et al (2009) Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development. PLoS One 4(8):e6612
72. Robbins SL, Kumar V, Cotran RS (2010) Robbins and Cotran pathologic basis of dise ase, 8th edn. Saunders, Elsevier, Philadelphia, PA, xiv, 1450 p
73. Rouaux C et al (2007) Sodium valproate exerts neuroprotective effects in vivo through CREBbinding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci 27(21):5535-5545 (Pubitemid 350021087)
74. Ryu H et al (2005) Sodium phenylbutyrate prolongs survival and regulates expression of antiapoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem 93(5):1087-1098 (Pubitemid 40776564)
75. Sandri M et al (2006) PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103(44):16260-16265 (Pubitemid 44715184)
76. Shen T et al (2006) Parallel mechanisms for resting nucleo-cytoplasmic shuttling and activity dependent translocation provide dual control of transcriptional regulators HDAC and NFAT in skeletal muscle fiber type plasticity. J Muscle Res Cell Motil 27(5-7):405-411 (Pubitemid 44325619)
77. Shi H et al (2008) Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. FASEB J 22(8):2990-3000
78. Spangenburg EE, Booth FW (2003) Molecular regulation of individual skeletal muscle fibre types. Acta Physiol Scand 178(4):413-424 (Pubitemid 36960433)
79. Sparrow DB et al (1999) MEF-2 function is modified by a novel co-repressor, MITR. EMBO J 18(18):5085-5098 (Pubitemid 29443810)
80. Sugai F et al (2004) Benefit of valproic acid in suppressing disease progression of ALS model mice. Eur J Neurosci 20(11):3179-3183 (Pubitemid 40007312)
81. Tang H, Goldman D (2006) Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade. Proc Natl Acad Sci USA 103(45):16977-16982 (Pubitemid 44737363)
82. Vadivelu SK et al (2004) Muscle regeneration and myogenic differentiation defects in mice lacking TIS7. Mol Cell Biol 24(8):3514-3525 (Pubitemid 38452090)
83. van der Linden AM, Nolan KM, Sengupta P (2007) KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC. EMBO J 26(2):358-370 (Pubitemid 46160937)
84. Vega RB et al (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119(4):555-566 (Pubitemid 39482354)
85. Verdin E, Dequiedt F, Kasler HG (2003) Class II histone deacetylases: versatile regulators. Trends Genet 19(5):286-293 (Pubitemid 36507011)
86. Vietor I et al (2005) TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent. J Biol Chem 280(48):39795-39801 (Pubitemid 41779112)
87. Wang AH, Yang XJ (2001) Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol 21(17):5992-6005 (Pubitemid 32737815)
88. Wang AH et al (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19(11):7816-7827 (Pubitemid 29493445)
89. Wang AH et al (2000) Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol Cell Biol 20(18):6904-6912
90. Welle S et al (2003) Gene expression profile of aging in human muscle. Physiol Genomics 14(2): 149-159 (Pubitemid 37345223)
91. Wen YD et al (2000) The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci USA 97(13):7202-7207
92. Williams AH et al (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959):1549-1554
93. Wu H et al (2000) MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 19(9):1963-1973 (Pubitemid 30237572)
94. Wu H et al (2001) Activation of MEF2 by muscle activity is mediated through a calcineurindependent pathway. EMBO J 20(22):6414-6423 (Pubitemid 33078714)
95. Wu H et al (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296(5566):349-352 (Pubitemid 34303690)
96. Yoon HG et al (2003) Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 22(6):1336-1346
97. Zhang CL et al (2001a) Association of COOH-terminal-binding protein (CtBP) and MEF2- interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 276(1):35-39 (Pubitemid 32050285)
98. Zhang CL, McKinsey TA, Olson EN (2001b) The transcriptional corepressor MITR is a signalresponsive inhibitor of myogenesis. Proc Natl Acad Sci USA 98(13):7354-7359 (Pubitemid 32567952)
99. Zhang CL, McKinsey TA, Olson EN (2002a) Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation. Mol Cell Biol 22(20):7302-7312
100. Zhang CL et al (2002b) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110(4):479-488 (Pubitemid 35232291)
101. Zhao X et al (2001) The modular nature of histone deacetylase HDAC4 confers phosphorylationdependent intracellular trafficking. J Biol Chem 276(37):35042-35048
102. Zhao X et al (2005) Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylasemediated lysine modifications. Mol Cell Biol 25(19):8456-8464 (Pubitemid 41369167)